Skip to main content
Clinical Trials/TCTR20180909001
TCTR20180909001
Recruiting
未知

Prognostic significance of urinary neutrophil gelatinase associated lipocalin for predicting chronic kidney disease in nonalcoholic fatty liver patients.

Ratchadaphiseksomphot Endowment Fund0 sites426 target enrollmentSeptember 9, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
chronic kidney diseasenonalcoholic fatty liver disease
Sponsor
Ratchadaphiseksomphot Endowment Fund
Enrollment
426
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2018
End Date
June 5, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ratchadaphiseksomphot Endowment Fund

Eligibility Criteria

Inclusion Criteria

  • nonalcoholic fatty liver patient who was diagnosed by liver biopsy or transient elastrography

Exclusion Criteria

  • have cancer
  • viral hepatitis B or C infection
  • alcohol consumption
  • acute kidney injury
  • End stage renal disease

Outcomes

Primary Outcomes

Not specified

Similar Trials